GP-Act III Acquisition Corp. Class A Ordinary Share (GPAT)
Official siteFINANCIAL SERVICES • SHELL COMPANIES • NASDAQ
Market Cap: $178.91M
Last updated: Nov 17, 2026 at 10:13 AM ET
GP-Act III Acquisition Corp. Class A Ordinary Share (GPAT) Financials: Revenue, Profit and Cash Flow
GP-Act III Acquisition Corp. Class A Ordinary Share reported revenue of $0 for the fiscal year ended Dec 31, 2025. That year, net income was $11.89M, operating cash flow was -$372.23K and free cash flow was -$372.23K. The quarter ended Sep 30, 2026 had revenue of $0 and net income of $581.51K.
Revenue and Margins
The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $551.92K.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $0 | N/A | N/A | N/A | N/A |
| Dec 2024 | $0 | N/A | N/A | N/A | N/A |
| Dec 2023 | $0 | N/A | N/A | N/A | N/A |
| Dec 2022 | $0 | N/A | N/A | N/A | N/A |
| Dec 2020 | N/A | N/A | N/A | N/A | N/A |
Income Statement
In the fiscal year ended Dec 2025, net income rose 37.1% from the year before. In the quarter ended Sep 2026, net income fell 81.3% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2020 |
|---|---|---|---|---|---|
| Operating income | -$551.92K | -$564.97K | -$14.04K | -$30.84K | -$3.97K |
| Net income | $11.89M | $8.67M | -$14.04K | -$30.84K | -$3.97K |
| EBITDA | -$551.92K | -$564.97K | -$14.04K | N/A | -$3.97K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income | -$316.10K | -$1.47M | -$565.28K | -$84.20K | -$126.33K | -$141.33K | -$200.05K | -$184.36K | -$143.46K | -$177.41K | -$59.74K | -$12.11K |
| Net income | $581.51K | $290.12K | $2.15M | $2.89M | $3.11M | $2.98M | $2.91M | $3.30M | $3.66M | $1.77M | -$59.74K | -$12.11K |
Balance Sheet
As of Dec 2025, short-term debt of $400.00K exceeded cash and equivalents by $287.34K. Shareholder equity was negative, at -$14.48M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2020 |
|---|---|---|---|---|---|
| Total assets | $309.37M | $297.47M | $530.24K | $1.06M | $287.93K |
| Current assets | $188.11K | $675.36K | $3.31K | $3.76K | N/A |
| Cash and equivalents | $112.66K | $483.57K | $1.21K | $1.76K | N/A |
| Total liabilities | $14.67M | $14.67M | $628.18K | $1.15M | $266.91K |
| Short-term debt | $400.00K | $400.00K | $628.18K | $464.59K | $113.10K |
| Shareholder equity | -$14.48M | -$13.93M | -$97.94K | -$83.90K | $21.03K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $99.38M | $98.35M | $312.11M | $309.37M | $306.50M | $303.42M | $300.49M | $297.47M | $294.10M | $290.45M | $1.27M | $530.24K |
| Total liabilities | $16.87M | $16.42M | $15.26M | $14.67M | $14.69M | $14.73M | $14.78M | $14.67M | $14.60M | $14.61M | $1.43M | $628.18K |
| Cash and equivalents | $193.45K | $10.59K | $119.43K | $112.66K | $145.45K | $246.31K | $376.57K | $483.57K | $513.51K | $571.76K | $153.20K | $1.21K |
| Shareholder equity | -$16.62M | -$16.30M | -$15.05M | $294.70M | -$14.40M | -$14.27M | -$14.13M | $282.80M | -$13.75M | -$13.60M | -$157.68K | -$97.94K |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2020 |
|---|---|---|---|---|---|
| Operating cash flow | -$372.23K | -$584.72K | -$10.97K | -$95.06K | N/A |
| Free cash flow | -$372.23K | -$584.72K | -$10.97K | -$95.06K | N/A |
| Share repurchases | $0 | $704.74K | $0 | N/A | N/A |
| Investing cash flow | $0 | -$287.50M | $0 | N/A | N/A |
| Financing cash flow | $1.31K | $288.57M | $10.42K | $94.05K | N/A |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$50.13K | -$188.84K | -$108.23K | $10.83K | -$100.86K | -$130.26K | -$151.94K | -$29.93K | -$58.26K | -$448.51K | -$48.01K | -$10.54K |
| Capital expenditures | N/A | N/A | $0 | $0 | $0 | $0 | $0 | $5 | $0 | $0 | $0 | $0 |
| Free cash flow | N/A | N/A | -$108.23K | $10.83K | -$100.86K | -$130.26K | -$151.94K | -$29.94K | -$58.26K | -$448.51K | -$48.01K | -$10.54K |
Frequently Asked Questions About GPAT
What is GP-Act III Acquisition Corp. Class A Ordinary Share's annual revenue?
GP-Act III Acquisition Corp. Class A Ordinary Share reported revenue of $0 for the fiscal year ended Dec 31, 2025.
Is GP-Act III Acquisition Corp. Class A Ordinary Share profitable?
Yes. GP-Act III Acquisition Corp. Class A Ordinary Share reported net income of $11.89M for the fiscal year ended Dec 31, 2025.
How much free cash flow does GPAT generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$372.23K minus capital expenditures of $0 produced free cash flow of -$372.23K.
How much debt does GP-Act III Acquisition Corp. Class A Ordinary Share have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $400.00K and cash and equivalents of $112.66K.
GPAT pages: Overview, Financials, Competitors